Quzhou City People's Hospital
In research, Quzhou City People's Hospital stands highest in Medicine (#2,940 of 10,443 worldwide), Health Sciences (#4,015 of 11,982 worldwide) and Life Sciences (#4,177 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 5.2× its share of world research.
- World rank, 2022–2025
- #7,421 of 28,054 · #17,691 all time
- Rank in China
- #1,495 of 3,058
- Research works
- 964 ▼ 11% vs 2013–17
- Citations
- 4.6k 4.8 per fractional work
- Top-10% rate
- 17.5% record average 16.5%
- Open access
- 47% world 28%
What is Quzhou City People's Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #2,940 of 10,443 | 16.5% | 216 | #7789 | |
| Health SciencesDomain | #4,015 of 11,982 | 17.0% | 225 | #9855 | |
| Life SciencesDomain | #4,177 of 7,800 | 15.8% | 100 | #8857 | |
| Biochemistry, Genetics and Molecular BiologyField | #3,150 of 3,579 | 14.9% | 69 | #6862 |
Each strip is that field’s whole ranked pool, with the notch where Quzhou City People's Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#7,789 #2,940
- Health Sciences#9,855 #4,015
- Life Sciences#8,857 #4,177
- Biochemistry, Genetics and Molecular Biology#6,862 #3,150
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Quzhou City People's Hospital specialise in?
Where its research is concentrated relative to its size: Oncology takes 5.2× the share of its output that it takes of world research.
- OncologySubfield · 22.0 works5.2×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.5×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 3.5×
- Medicine 3.0×
- Immunology and Microbiology 3.0×
- Pharmacology, Toxicology and Pharmaceutics 2.7×
- Neuroscience 2.1×
- Dentistry 1.4×
- Nursing 1.2×
- Chemistry 0.7×
- Materials Science 0.6×
- Veterinary 0.5×
- Psychology 0.5×
- Health Professions 0.4×
- Environmental Science 0.3×
- Engineering 0.3×
- Chemical Engineering 0.2×
- Energy 0.2×
- Computer Science 0.2×
- Agricultural and Biological Sciences 0.2×
- Physics and Astronomy 0.1×
- Mathematics 0.1×
- Decision Sciences 0.1×
- Social Sciences 0.1×
- Economics, Econometrics and Finance 0.0×
- Earth and Planetary Sciences 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Quzhou City People's Hospital?
Ranked on the composite score, Feng Zhang and Junhui Wang lead among researchers whose main affiliation is Quzhou City People's Hospital.
- 1 Feng Zhang China · #419,743 worldwide 87 citations · 24 works
- 2 Junhui Wang China · #1,504,423 worldwide 7 citations · 18 works
Which keywords describe research at Quzhou City People's Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Cancer, Epidemiology, Tumor Microenvironment, Oxidative Stress, Biomarkers, Metastasis and Chemotherapy.
- Lipid Peroxidation
- Immune Checkpoint Blockade
- Epigenetic Regulation
- Radiotherapy
- Rehabilitation
- Biogenesis
- Neuroinflammation
- Mortality
- Regulation
- Prognostic Factors
- Immunity
- Immune Response
- Metabolic Syndrome
- Immunotherapy
- Management
- Cardiovascular Disease
- Chemotherapy
- Biomarkers
- Oxidative Stress
- Epidemiology
- Inflammation
- Cancer
- Tumor Microenvironment
- Treatment
- Gene Expression
- Diagnosis
- Metastasis
- Clinical Practice Guidelines
- Risk Factors
- Cell Death
- Global Burden
- Metabolism
- Cancer Therapy
- Angiogenesis
- Prognosis
- Precision Medicine
- Cancer Progression
- Apoptosis
- Thrombosis
- PD-1 and PD-L1
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation34▲ 4.4×70 topics
- Epidemiology33▲ 2.2×89 topics
- Cancer29▲ 5.8×41 topics
- Oxidative Stress21▲ 3.4×46 topics
- Tumor Microenvironment16▲ 9.6×8 topics
- Biomarkers13▲ 5.1×14 topics
- Treatment13▲ 2.9×33 topics
- Chemotherapy13▲ 4.9×20 topics
- Gene Expression12▲ 5.2×11 topics
- Cardiovascular Disease12▲ 2.8×29 topics
- Diagnosis12▲ 3.3×26 topics
- Management11▲ 3.9×21 topics
- Metastasis10▲ 8.3×11 topics
- Immunotherapy10▲ 3.7×17 topics
- Clinical Practice Guidelines10▲ 4.7×13 topics
- Metabolic Syndrome10▲ 3.1×20 topics
- Risk Factors9▲ 2.1×23 topics
- Immune Response8▲ 4.0×16 topics
- Cell Death8▲ 9.4×6 topics
- Immunity8▲ 5.2×8 topics
- Global Burden7▲ 3.7×11 topics
- Prognostic Factors7▲ 4.5×13 topics
- Metabolism7▲ 3.7×19 topics
- Regulation7▲ 3.5×8 topics
- Cancer Therapy7▲ 3.3×14 topics
- Mortality7▲ 3.2×11 topics
- Angiogenesis7▲ 5.5×14 topics
- Neuroinflammation7▲ 6.3×6 topics
- Prognosis7▲ 5.4×9 topics
- Biogenesis6▲ 9.8×3 topics
- Precision Medicine6▲ 3.6×7 topics
- Rehabilitation6▲ 4.2×8 topics
- Cancer Progression6▲ 8.4×8 topics
- Radiotherapy6▲ 4.1×9 topics
- Apoptosis6▲ 4.8×18 topics
- Epigenetic Regulation5▲ 6.5×5 topics
- Thrombosis5▲ 5.1×7 topics
- Immune Checkpoint Blockade4▲ 11×1 topic
- PD-1 and PD-L14▲ 11×1 topic
- Lipid Peroxidation4▲ 11×3 topics
Which research topics does Quzhou City People's Hospital publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, RNA modifications and cancer, Ferroptosis and cancer prognosis and MicroRNA in disease regulation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 4 works
- 2 RNA modifications and cancer Molecular Biology 4 works
- 3 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 4 works
- 4 MicroRNA in disease regulation Cancer Research 3 works
- 5 Inflammatory Biomarkers in Disease Prognosis Oncology 3 works
- 6 Gut microbiota and health Molecular Biology 3 works
- 7 Cancer-related molecular mechanisms research Cancer Research 3 works
- 8 Inflammasome and immune disorders Molecular Biology 2 works
- 9 Immune cells in cancer Immunology 2 works
- 10 Advanced biosensing and bioanalysis techniques Molecular Biology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Quzhou City People's Hospital's research output changed?
Output in 2018–2022 was 11% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Quzhou
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.